Black Rock Inc. Tempest Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Tempest Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 508,195 shares of TPST stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

508,195

Previous 508,928 0.14%

Holding current value

$1.03 Million

Previous $2.24 Million 11.26%

% of portfolio

0.0%

Previous 0.0%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$3.16 - $4.66 $2,316 - $3,415	-733 Reduced 0.14%	508,195 $1.99 Million
Q4 2023 Feb 13, 2024	BUY	$0.23 - $9.77 $97,946 - $4.16 Million	425,855 Added 512.63%	508,928 $2.24 Million
Q4 2021 Feb 10, 2022	BUY	$5.28 - $15.2 $1,980 - $5,700	375 Added 0.45%	83,073 $438,000
Q3 2021 Nov 09, 2021	BUY	$10.49 - $24.19 $815,901 - $1.88 Million	77,779 Added 1581.2%	82,698 $1.2 Million
Q2 2021 Aug 11, 2021	BUY	$11.18 - $22.95 $54,994 - $112,891	4,919 New	4,919 $55,000

Others Institutions Holding TPST

# of Institutions

Shares Held

1.43M

Call Options Held

161K

Put Options Held

78K

View Full List

About Tempest Therapeutics, Inc.

Ticker TPST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,418,900
Market Cap $21M
Description
Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...

More about TPST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account